These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abnormal urinary kallikrein in hypertension is not related to aldosterone or plasma renin activity. Lawton WJ; Fitz AE Hypertension; 1980; 2(6):787-93. PubMed ID: 7007236 [TBL] [Abstract][Full Text] [Related]
3. Urinary kallikrein excretion in essential and mineralocorticoid hypertension. Holland OB; Chud JM; Braunstein H J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684 [TBL] [Abstract][Full Text] [Related]
4. Increased urinary kallikrein excretion in young borderline hypertensive patients. Ando K; Fujita T Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868 [TBL] [Abstract][Full Text] [Related]
5. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. Horwitz D; Margolius HS; Keiser HR J Clin Endocrinol Metab; 1978 Aug; 47(2):296-9. PubMed ID: 263797 [TBL] [Abstract][Full Text] [Related]
6. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension. Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897 [TBL] [Abstract][Full Text] [Related]
7. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. Levy SB; Lilley JJ; Frigon RP; Stone RA J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078 [TBL] [Abstract][Full Text] [Related]
8. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system. Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244 [TBL] [Abstract][Full Text] [Related]
9. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia. Nakada T Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065 [TBL] [Abstract][Full Text] [Related]
10. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054 [TBL] [Abstract][Full Text] [Related]
11. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367 [TBL] [Abstract][Full Text] [Related]
12. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction. Sanchez R; Gimenez MI; Ramos F; Baglivo H; Ramirez AJ J Hypertens; 1996 Nov; 14(11):1287-91. PubMed ID: 8934356 [TBL] [Abstract][Full Text] [Related]
13. The effect of sodium and potassium loading on urinary kallikrein-like activity in young patients with borderline hypertension. Ando K; Ito Y; Noda H; Fujita T Jpn Circ J; 1985 Nov; 49(11):1151-8. PubMed ID: 3854057 [TBL] [Abstract][Full Text] [Related]
14. Urinary kallikrein in normotensive subjects and in patients with essential hypertension. Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466 [TBL] [Abstract][Full Text] [Related]
15. [Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension]. Musca A; Ferri C; Cammerella I; Onofri R; Tani S; Santucci A Medicina (Firenze); 1989; 9(2):167-72. PubMed ID: 2530412 [TBL] [Abstract][Full Text] [Related]
16. Urinary kallikrein and salt sensitivity in essential hypertensive males. Ferri C; Bellini C; Carlomagno A; Perrone A; Santucci A Kidney Int; 1994 Sep; 46(3):780-8. PubMed ID: 7996800 [TBL] [Abstract][Full Text] [Related]
17. Urinary kallikrein in normotensive subjects and in patients with essential hypertension. Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074 [TBL] [Abstract][Full Text] [Related]
18. Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels. Koolen MI; Daha MR; Frölich M; Van Es LA; Van Brummelen P Eur J Clin Invest; 1984 Jun; 14(3):171-4. PubMed ID: 6432545 [TBL] [Abstract][Full Text] [Related]
19. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension]. Marzecka J Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117 [TBL] [Abstract][Full Text] [Related]
20. [Correlations between circulation levels of natriuretic atrial peptide and urinary excretion of kallikrein in young normotensive and hypertensive subjects]. Ferri C; Cammarella I; Giarrizzo C; Bellini C; Astorre P; Di Zenzo P; Santucci A; Musca A; Balsano F Ann Ital Med Int; 1991; 6(2):217-23. PubMed ID: 1836137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]